{"disease":{"id":"lymphocyte-depletion","name":"lymphocyte depletion"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04273893","title":"Lymphocyte Depletion and Change in Lymphocyte Functionality","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":55,"lead_sponsor_name":"University of Virginia","has_results":true},{"nct_id":"NCT01535924","title":"Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Beth Christian","has_results":true},{"nct_id":"NCT01460940","title":"A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}